Vanguard Capital Management’s Damora Therapeutics DMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding DMRA
Vanguard Capital Management's DMRA Position: Q3 2026 in Review
Vanguard Capital Management increased its Damora Therapeutics (DMRA) stake by 162% in Q3 2026, buying an estimated $9.8M and bringing the position to 557,495 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2664.
Vanguard Capital Management first reported a position in DMRA in Q1 2026 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.
- Vanguard Capital Management held 557,495 shares of Damora Therapeutics worth $11.9M as of Q3 2026.
- Vanguard Capital Management bought 344,895 Damora Therapeutics shares in Q3 2026, an estimated $9.8M.
- Damora Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2664 holding.
- Vanguard Capital Management first reported a position in Damora Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.